174
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Patterns of Variation Influencing Antipsychotic Treatment Outcomes in South African First-Episode Schizophrenia Patients

, , , , , , , & show all
Pages 189-199 | Received 08 Jul 2013, Accepted 24 Oct 2013, Published online: 21 Jan 2014

References

  • Manolio TA , CollinsFS, CoxNJ et al. Finding the missing heritability of complex diseases. Nature 461(7265) , 747–753 (2009).
  • Girard SL , DionPA, RouleauGA. Schizophrenia genetics: putting all the pieces together. Curr. Neurol. Neurosci. Rep.12(3) , 261–266 (2012).
  • Arranz MJ , KapurS. Pharmacogenetics in psychiatry: are we ready for widespread clinical use? Schizophr. Bull.34(6) , 1130–1144 (2008).
  • Sullivan PF , DalyMJ, O‘DonovanM. Genetic architectures of psychiatric disorders: the emerging picture and its implications. Nat. Rev. Genet.13(8) , 537–551 (2012).
  • Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium. Genome-wide association study identifies five new schizophrenia loci. Nat. Genet.43(10) , 969–976 (2011).
  • Lander ES . QnAs with Eric S. Lander. Interview by Prashant Nair. Proc. Natl Acad. Sci. USA108(28) , 11319 (2011).
  • Xu B , RoosJL, DexheimerP et al. Exome sequencing supports a de novo mutational paradigm for schizophrenia. Nat. Genet. 43(9) , 864–868 (2011).
  • Xu B , Ionita-LazaI, RoosJL et al. De novo gene mutations highlight patterns of genetic and neural complexity in schizophrenia. Nat. Genet.44(12) , 1365–1369 (2012).
  • Girard SL , GauthierJ, NoreauA et al. Increased exonic de novo mutation rate in individuals with schizophrenia. Nat. Genet. 43(9) , 860–863 (2011).
  • Need AC , McEvoyJP, GennarelliM et al. Exome sequencing followed by large-scale genotyping suggests a limited role for moderately rare risk factors of strong effect in schizophrenia. Am. J. Hum. Genet. 91(2) , 303–312 (2012).
  • Malhotra D , SebatJ. CNVs: harbingers of a rare variant revolution in psychiatric genetics. Cell148(6) , 1223–1241 (2012).
  • Cole J . Evaluation of drug treatments in psychiatry. Proc. Annu. Meet. Am. Psychopathol. Assoc.52 , 14–31 (1964).
  • Leucht S , BarnesTR, KisslingW, EngelRR, CorrellC, KaneJM. Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials. Am. J. Psychiatry160(7) , 1209–1222 (2003).
  • Kahn RS , FleischhackerWW, BoterH et al. Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial. Lancet 371(9618) , 1085–1097 (2008).
  • Mas S , LlerenaA, SaízJ, BernardoM, LafuenteA. Strengths and weaknesses of pharmacogenetic studies of antipsychotic drugs: the potential value of the PEPs study. Pharmacogenomics13(15) , 1773–1782 (2012).
  • Arranz MJ , RiveraM, MunroJC. Pharmacogenetics of response to antipsychotics in patients with schizophrenia. CNS Drugs25(11) , 933–969 (2011).
  • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR). American Psychiatric Association, Washington, DC, USA (1994).
  • Wright GEB , NiehausDJH, van der Merwe L et al. Association of MB-COMT polymorphisms with schizophrenia-susceptibility and symptom severity in an African cohort. Prog. Neuropsychopharmacol. Biol. Psychiatry39(1) , 163–169 (2012).
  • Li H , DurbinR. Fast and accurate short read alignment with burrows-wheeler transform. Bioinformatics25(14) , 1754–1760 (2009).
  • Li H , HandsakerB, WysokerA et al. The sequence alignment/map format and SAM tools. Bioinformatics 25(16) , 2078–2079 (2009).
  • DePristo MA , BanksE, PoplinR et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat. Genet. 43(5) , 491–498 (2011).
  • Milacic M , HawR, RothfelsK et al. Annotating cancer variants and anti-cancer therapeutics in reactome. Cancers 4(4) , 1180–1211 (2012).
  • Croft D , O‘KellyG, WuG et al. Reactome: a database of reactions, pathways and biological processes. Nucleic Acids Res. 39(Database issue) , D691–D697 (2011).
  • Schuster SC , MillerW, RatanA et al. Complete Khoisan and Bantu genomes from southern Africa. Nature 463(7283) , 943–947 (2010).
  • Wright GE , NiehausDJ, KoenL, DrogemollerBI, WarnichL. Psychiatric genetics in South Africa: cutting a rough diamond. Afr. J. Psychiatry (Johannesburg)14(5) , 355–366 (2011).
  • Drogemoller BI , WrightGEB, NiehausDJH, EmsleyRA, WarnichL. Whole-genome resequencing in pharmacogenomics: moving away from past disparities to globally representative applications. Pharmacogenomics12(12) , 1717–1728 (2011).
  • Cao D , RussellRL, ZhangD, LeffertJJ, PizzornoG. Uridine phosphorylase (-/-) murine embryonic stem cells clarify the key role of this enzyme in the regulation of the pyrimidine salvage pathway and in the activation of fluoropyrimidines. Cancer Res.62(8) , 2313–2317 (2002).
  • Roosild TP , CastronovoS, VillosoA, ZiembaA, PizzornoG. A novel structural mechanism for redox regulation of uridine phosphorylase 2 activity. J. Struct. Biol.176(2) , 229–237 (2011).
  • Myers CS , FisherH, WagnerGC. Uridine potentiates haloperidol‘s disruption of conditioned avoidance responding. Brain Res.651(1–2) , 194–198 (1994).
  • Putnam DK , SunJ, ZhaoZ. Exploring schizophrenia drug–gene interactions through molecular network and pathway modeling. AMIA Annu. Symp. Proc.2011 , 1127–1133 (2011).
  • Zandi PP , JudyJT. The promise and reality of pharmacogenetics in psychiatry. Psychiatr. Clin. North Am.33(1) , 181–224 (2010).
  • Lim ET , RaychaudhuriS, SandersSJ et al. Rare complete knockouts in humans: population distribution and significant role in autism spectrum disorders. Neuron 77(2) , 235–242 (2013).
  • Smoller JW , CraddockN, KendlerK et al. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 381(9875) , 1371–1379 (2013).
  • Jouan L , GirardSL, DobrzenieckaS et al. Investigation of rare variants in LRP1, KPNA1, ALS2CL and ZNF480 genes in schizophrenia patients reflects genetic heterogeneity of the disease. Behav. Brain Funct. 9 , 9 (2013).
  • Gratten J , VisscherPM, MowryBJ, WrayNR. Interpreting the role of de novo protein-coding mutations in neuropsychiatric disease. Nat. Genet.45(3) , 234–238 (2013).
  • Abecasis GR , AutonA, BrooksLD et al. An integrated map of genetic variation from 1,092 human genomes. Nature 491(7422) , 56–65 (2012).
  • Kiezun A , GarimellaK, DoR et al. Exome sequencing and the genetic basis of complex traits. Nat. Genet. 44(6) , 623–630 (2012).

▪ Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.